{"id":55252,"date":"2023-03-28T13:07:25","date_gmt":"2023-03-28T11:07:25","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/genesiscare-launches-viewray-mridian-mri-guided-radiation-therapy-system-at-lee-health-regional-cancer-center-empowering-cancer-patient-care-with-an-innovative-radiotherapy-approach-with-reduce\/"},"modified":"2023-03-28T13:07:25","modified_gmt":"2023-03-28T11:07:25","slug":"genesiscare-launches-viewray-mridian-mri-guided-radiation-therapy-system-at-lee-health-regional-cancer-center-empowering-cancer-patient-care-with-an-innovative-radiotherapy-approach-with-reduce","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/genesiscare-launches-viewray-mridian-mri-guided-radiation-therapy-system-at-lee-health-regional-cancer-center-empowering-cancer-patient-care-with-an-innovative-radiotherapy-approach-with-reduce\/","title":{"rendered":"GenesisCare Launches ViewRay MRIdian\u00ae MRI-Guided Radiation Therapy System at Lee Health Regional Cancer Center, Empowering Cancer Patient Care with an Innovative Radiotherapy Approach with Reduced Side Effects, Fewer Sessions Needed"},"content":{"rendered":"
\n

\nGenesisCare\u2019s first MRIdian\u00ae in the U.S., one of only 28 in the U.S., will improve patient access to advanced technology that reduces the burden of treatment for patients with prostate, breast, or pancreatic tumors<\/i>\n<\/p>\n

FORT MYERS, Fla.–(BUSINESS WIRE)–GenesisCare, one of the leading integrated cancer care providers in the United States, Australia, Spain, and the United Kingdom, will launch ViewRay\u2019s advanced MRIdian MRI-guided radiation therapy system at the Lee Health Regional Cancer Center on Monday, March 27, at its Fort Myers, FL location<\/a>. Providing access to the precision of MRIdian Stereotactic MRI-guided Adaptive Radiotherapy (SMART) therapy in a community cancer care setting may help reduce the burden of cancer treatment for patients who choose GenesisCare.\n<\/p>\n

<\/a><\/p>\n

\nOne of the most advanced radiotherapy options available in the United States, MRIdian combines precision radiation therapy with cutting-edge, high-resolution magnetic resonance imaging (MRI) guidance, optimizing treatment so that fewer sessions may be required. GenesisCare Fort Myers is the first location in Southwest Florida to offer a radiotherapy system with diagnostic-quality MRI with an advanced linear accelerator and only the 28th MRIdian location in the United States. This will be the third MRIdian system within GenesisCare\u2019s global network to treat patients, with well-established centers in Oxford and Windsor in the United Kingdom.\n<\/p>\n

\n\u201cAfter learning of the system\u2019s capabilities, including the preciseness of the power and the targeted beam to the treatment area with reduced incidence of damage to surrounding tissue, I felt comfortable waiting for this machine to become available,\u201d said prostate cancer patient Harold Fowler. \u201cMy family and I met with Dr. Rodney Ellis, my radiation oncologist here in Cape Coral, Florida, and we all agreed that waiting for this machine was the choice best suited to our situation. I\u2019m ready to begin the treatment plan with this machine as soon as it becomes available.\u201d\n<\/p>\n

\nFindings published in JAMA Oncology<\/a> demonstrated the superiority of MRIdian MRI guidance in stereotactic body radiation therapy (SBRT) for localized prostate cancer compared to CT-guided SBRT. The study involving 156 patients:\n<\/p>\n